December 2021

A Practical Approach to Chronic Immunosuppression in Myasthenia Gravis

December 24, 2021

Features

A practical approach to initiating and tapering corticosteroids, and the considerations in the selection and monitoring parameters of steroid-sparing agents are crucial to the care of myasthenia gravis.

Confirming the Benefits of Tenecteplase for Acute Ischemic Stroke in TIMELESS

December 23, 2021

Clinical Trial Focus

After years of research showing that it demonstrates similar benefit to alteplase, tenecteplase’s benefit in a large patient cohort with acute ischemic stroke will be tested in the TIMELESS trial.

Serotonin Receptor Agonism in Dravet Syndrome

December 21, 2021

NeuroPathways

As Dravet syndrome is often nonresponsive to existing therapeutics, it can be a challenge to treat, and this refractory nature creates a great need for novel, innovative, and safe antiepileptic drugs for its treatment.

An Emerging Framework for Parkinson Disease Therapeutics

December 20, 2021

Letter From the Editor

The diagnosis of Parkinson disease may seem straightforward at first, requiring neurologists to rely on their eyes and hands, but the treatment process can present challenges for both physicians and patients.

Inadequate Medical Information Available Regarding Cannabis Use in MS

October 27, 2021

Conference Coverage

All told, 48% of patients with MS reported that their most common primary person for guidance on cannabis use in MS was themself or no one, followed by a dispensary professional and MS physician.